BSI 729
Alternative Names: BSI-729Latest Information Update: 30 Aug 2023
At a glance
- Originator Biosion
- Class Antineoplastics; Bispecific antibodies; Immunotherapies
- Mechanism of Action Immunomodulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Solid tumours
Most Recent Events
- 02 Aug 2023 Preclinical trials in Solid tumours in China (Parenteral) (Biosion pipeline, August 2023)